Novonix Limited NVNXF
$0.09
$0.0219.47%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.80M | 4.21M | 5.62M | 5.77M | 5.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.80M | 4.21M | 5.62M | 5.77M | 5.93M |
| Cost of Revenue | 1.86M | 1.86M | 1.86M | 1.31M | 765.00K |
| Gross Profit | 942.60K | 942.60K | 942.60K | 1.65M | 2.35M |
| SG&A Expenses | 37.50M | 38.86M | 40.22M | 40.68M | 41.14M |
| Depreciation & Amortization | 4.77M | 4.45M | 4.13M | 4.15M | 4.16M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.48M | 51.58M | 51.69M | 51.21M | 50.72M |
| Operating Income | -48.68M | -48.78M | -48.89M | -48.25M | -47.61M |
| Income Before Tax | -96.15M | -93.09M | -90.03M | -76.75M | -63.47M |
| Income Tax Expenses | 25.60K | 25.60K | 25.60K | 61.60K | 97.60K |
| Earnings from Continuing Operations | -96.17 | -93.11 | -90.05 | -76.81 | -63.57 |
| Earnings from Discontinued Operations | -1.05M | -1.86M | -2.67M | -2.67M | -2.67M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.22M | -94.97M | -92.73M | -79.49M | -66.25M |
| EBIT | -48.68M | -48.78M | -48.89M | -48.25M | -47.61M |
| EBITDA | -44.57M | -45.00M | -45.43M | -44.75M | -44.07M |
| EPS Basic | -0.13 | -0.13 | -0.13 | -0.13 | -0.12 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.04 | -0.05 | -0.06 |
| EPS Diluted | -0.14 | -0.14 | -0.14 | -0.13 | -0.13 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.05 | -0.06 |
| Average Basic Shares Outstanding | 3.20B | 2.96B | 2.73B | 2.50B | 2.27B |
| Average Diluted Shares Outstanding | 3.20B | 2.96B | 2.73B | 2.50B | 2.27B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |